🇺🇸 Beijing hypotensive No.0 in United States
1 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 1
Most-reported reactions
- Drug Eruption — 1 report (100%)
Other Cardiovascular approved in United States
Frequently asked questions
Is Beijing hypotensive No.0 approved in United States?
Beijing hypotensive No.0 does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Beijing hypotensive No.0 in United States?
West China Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.